TAK-475, a squalene synthase inhibitor, improves lipid profile in hyperlipidernic subjects

被引：0
|
作者：
Piper, Ed
Price, Graham
Chen, Yinzhong
机构：
[1] Takeda Global Rsch & Dev Ctr Europe Ltd, London, England
[2] Takeda Global Rsch & Dev Ctr Inc, Lincolnshire, IL USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs
    Ebihara, T.
    Teshima, K.
    Kondo, T.
    Tagawa, Y.
    Moriwaki, T.
    Asahi, S.
    DRUG RESEARCH, 2016, 66 (06) : 287 - 292
  • [2] Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro
    Nishimoto, T
    Amano, Y
    Tozawa, R
    Ishikawa, E
    Imura, Y
    Yukimasa, H
    Sugiyama, Y
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (05) : 911 - 918
  • [3] Drug evaluation: TAK-475 - an oral inhibitor of squalene synthase for hyperlipidemia
    Burnett, John R.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (09) : 850 - 856
  • [4] Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia
    Amano, Y
    Nishimoto, T
    Tozawa, R
    Ishikawa, E
    Imura, Y
    Sugiyama, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 466 (1-2) : 155 - 161
  • [5] TAK-475, a squalene synthase inhibitor, coadministered with atorvastatin: A pharmacokinetic study.
    Piper, E.
    Price, G.
    Munsaka, M.
    Karim, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S37 - S37
  • [6] TAK-475, a squalene synthase inhibitor: Mass balance and excretion study.
    Karim, A.
    Abeyratne, A.
    Siebert, F.
    Hetman, L.
    Teshima, K.
    Kondo, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S114 - S114
  • [7] Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
    Rimondi, Erika
    Valencic, Erica
    Tommasini, Alberto
    Secchiero, Paola
    Melloni, Elisabetta
    Marcuzzi, Annalisa
    BIOMOLECULES, 2021, 11 (10)
  • [8] Discovery of the 4,1-benzoxazepine derivative TAK-475 as squalene synthase inhibitor.
    Kori, M
    Miki, T
    Mabuchi, H
    Tozawa, RI
    Nishimoto, T
    Sugiyama, Y
    Teshima, K
    Yukimasa, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U216 - U216
  • [9] Hypolipidemic and anti-atherosclerotic effects of a squalene synthase inhibitor, TAK-475, in WHHLMI rabbits
    Shiomi, M.
    Yamada, S.
    Amano, Y.
    Nishimoto, T.
    Ito, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 549 - 549
  • [10] Process Research on the Asymmetric Hydrogenation of a Benzophenone for Developing the Manufacturing Process of the Squalene Synthase Inhibitor TAK-475
    Goto, Mitsutaka
    Konishi, Takahiro
    Kawaguchi, Shinji
    Yamada, Masatoshi
    Nagata, Toshiaki
    Yamano, Mitsuhisa
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (05) : 1178 - 1184
12345